BRIEF published on 10/23/2024 at 10:05, 1 year 1 month ago BERLANDES Dévoile des Capsules Ovariennes Innovantes Innovation Biomédicale Santé Reproductive BERLANDES Capsules Ovariennes Nutriments Féminins
BRIEF published on 10/23/2024 at 10:05, 1 year 1 month ago BERLANDES Unveils Innovative Ovarian Capsules Biomedical Innovation BERLANDES Reproductive Health Ovarian Capsules Female Nutrients
PRESS RELEASE published on 10/23/2024 at 10:00, 1 year 1 month ago BERLANDES Lance des Capsules Ovariennes Anti-Âge Innovantes BERLANDES lance les Capsules Ovariennes PCCIDINCT2™ pour soutenir la santé ovarienne et traiter les problèmes de santé reproductive chez les femmes, combinant la régénération cellulaire et la biotechnologie de pointe Biotechnologie BERLANDES Capsules Ovariennes PCCIDINCT2 Santé Ovarienne
BRIEF published on 10/22/2024 at 13:05, 1 year 1 month ago BERLANDES Introduces PCCIDINCT2™ Ovarian Capsules Biotechnology Women's Health BERLANDES Ovarian Health PCCIDINCT2™
BRIEF published on 10/22/2024 at 13:05, 1 year 1 month ago BERLANDES présente les capsules ovariennes PCCIDINCT2™ Biotechnologie Santé Des Femmes BERLANDES PCCIDINCT2™ Santé Des Ovaires
PRESS RELEASE published on 10/22/2024 at 13:00, 1 year 1 month ago BERLANDES Launches Innovative Anti-Aging Ovarian Capsules BERLANDES launches PCCIDINCT2™ Ovarian Capsules aiming to support ovarian health and address reproductive health issues among women. The product is a result of cutting-edge research in biotechnology and cellular regeneration Biotechnology Women's Health BERLANDES PCCIDINCT2™ Ovarian Capsules Reproductive Health
Published on 12/05/2025 at 02:35, 4 hours 54 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 29 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 24 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 29 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 29 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 59 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 38 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 4 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 14 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:14, 13 hours 14 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 13 hours 29 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 13 hours 29 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 44 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 13 hours 44 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
